DISH.L

BigDish Plc
Amala Foods PLC - Transaction Update
24th April 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 7917L
Amala Foods PLC
24 April 2024
 

 

Amala Foods Plc

("Amala" or the "Company")

 

Transaction Update

 

Amala Foods Plc (LON: DISH) is pleased to announce a further update following the Temporary Suspension of its listing on the Standard Segment of the Official List of the Main Market that was first announced on 9 November 2023 and subsequently on 4 January 2024. 

The Company is pleased to update the market that the announced transaction continues to progress.  The Company has made further prospectus submissions to the Financial Conduct Authority (FCA) and anticipates its next submission within the coming weeks once the audited numbers of the target company are available. 

As previously announced the target company is a newly formed healthcare group, Healthcare Medical Plus Pte Ltd with a Philippine subsidiary, Dialysis Care Plus Inc, which is building dialysis centres in the Philippines where the market for dialysis services is growing substantially every year.  The group continues to grow and has executed agreements to acquire, prior to Admission, of a diagnostic centre, that has a multiyear positive track record.  In addition, the group has formed a new subsidiary, VidaHealth Inc which has funded a new diagnostic clinic where it has a 70% interest and has an Option to build a further 50 diagnostic centres. 

The Directors are targeting that the transaction will be concluded in the summer of 2024 and the Directors will provide further updates to the market in due course. 

Whilst the Directors are confident that a successful transaction will result in a Reverse Takeover, subject to regulatory approval, there can be no guarantee of such.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 ("MAR").

 

Enquiries:

 

Jonathan Morley-Kirk, Non-Executive Chairman

jmk@bluebirdmv.com  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSELSFLELSEDL]]>
TwitterFacebookLinkedIn